NasdaqGS - Delayed Quote • USD
Surgery Partners, Inc. (SGRY)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 4:03 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 10 | 10 | 11 | 11 |
Avg. Estimate | 0.07 | 0.19 | 0.99 | 1.27 |
Low Estimate | 0.02 | 0.13 | 0.78 | 1.16 |
High Estimate | 0.12 | 0.23 | 1.12 | 1.49 |
Year Ago EPS | 0.08 | 0.28 | 1 | 0.99 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 9 | 9 | 10 | 10 |
Avg. Estimate | 697.42M | 728.8M | 3.01B | 3.27B |
Low Estimate | 688M | 708M | 3B | 3.24B |
High Estimate | 726.82M | 737.3M | 3.02B | 3.32B |
Year Ago Sales | 666.2M | 667.6M | 2.74B | 3.01B |
Sales Growth (year/est) | 4.70% | 9.20% | 9.60% | 8.80% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | 0 | 0.08 | 0.16 | 0.38 |
EPS Actual | 0.08 | 0.28 | 0.19 | 0.44 |
Difference | 0.08 | 0.2 | 0.03 | 0.06 |
Surprise % | -- | 250.00% | 18.80% | 15.80% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0.07 | 0.19 | 0.99 | 1.27 |
7 Days Ago | 0.08 | 0.19 | 1 | 1.28 |
30 Days Ago | 0.08 | 0.19 | 1 | 1.28 |
60 Days Ago | 0.12 | 0.21 | 1.06 | 1.37 |
90 Days Ago | 0.11 | 0.2 | 1.05 | 1.33 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | 1 | -- | 1 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Growth Estimates
CURRENCY IN USD | SGRY | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -12.50% | -- | -- | 1.60% |
Next Qtr. | -32.10% | -- | -- | 10.50% |
Current Year | -1.00% | -- | -- | 5.20% |
Next Year | 28.30% | -- | -- | 13.30% |
Next 5 Years (per annum) | 45.50% | -- | -- | 11.22% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
Earnings
Upgrades & Downgrades
Reiterates | Cantor Fitzgerald: Overweight to Overweight | 4/10/2024 |
Initiated | Barclays: Equal-Weight | 3/6/2024 |
Reiterates | Cantor Fitzgerald: Overweight to Overweight | 3/5/2024 |
Reiterates | RBC Capital: Outperform to Outperform | 2/29/2024 |
Maintains | Citigroup: Buy to Buy | 2/27/2024 |
Maintains | Cantor Fitzgerald: Overweight to Overweight | 2/27/2024 |
Related Tickers
ACHC Acadia Healthcare Company, Inc.
70.16
-0.17%
USPH U.S. Physical Therapy, Inc.
99.09
+1.64%
OPCH Option Care Health, Inc.
31.08
+0.58%
THC Tenet Healthcare Corporation
93.19
+2.32%
SEM Select Medical Holdings Corporation
27.06
+2.38%
ADUS Addus HomeCare Corporation
97.19
+0.03%
INNV InnovAge Holding Corp.
3.9500
-1.25%
ENSG The Ensign Group, Inc.
118.26
+1.53%
AMN AMN Healthcare Services, Inc.
56.95
+1.15%
EHC Encompass Health Corporation
79.22
+0.76%